The Headlines
The Headlines

A MAGA Victory in Texas, and the Trump Administration’s New Ebola Plan

1d ago8:371,446 words
0:000:00

Plus, Iran begins lifting an internet blackout.  Here’s what we’re covering: Paxton’s Texas Victory Opens a New Front in the Battle for the Senate, by Lisa Lerer and Reid J. Epstein Trump Administrati...

Transcript

EN

Hi, it's Alexa Waibel from New York Times Cooking.

We've got tons of easy, weak-knit recipes,

and today I'm making my five ingredient creamy miso pasta.

You just take your star-cheap pasta water, whisk it together with a little bit of miso and butter until it's creamy, add your noodles and a little bit of cheese. Hmm, it's like a grown-up box of mac and cheese, that feels like a restaurant quality dish.

New York Times Cooking has you covered with easy dishes for busy weak-knights. You can find more at NYT Cooking.com. From the New York Times, it's the headlines. I'm Tracy Mumford. Today's Wednesday, May 27th.

Here's what we're covering.

Tonight, we just sent a Texas-sized message to Washington. [CHEERING] Change was on the ballot, and change won. [CHEERING] In Texas, Ken Paxton, the state's far-right

attorney general with a long history of scandal and controversy,

took down longtime Senator John Cornean.

It was essentially a decisive victory for the mag movement over the state's old guard of conservatives. President Trump is a leader of our party, and his endorsement is the most powerful force in politics. The runoff election was the most expensive primary in American history,

and Paxton pulled out a win despite being outspent on ads by roughly $80 million.

The endorsement of President Trump helped carry him

to what is, as of right now, a nearly 30-point win over Cornean. And it has proved, once again, that when Trump backs a candidate, he brings voters with him. That's been the case in Louisiana, Kentucky, and Indiana, where just in the last few weeks, the president's preferred candidates

have all taken down GOP incumbents that Trump turned on. Now, looking ahead to November, Democrats actually see Paxton's primary victory as an opportunity for them. They see an opening to run against Paxton for his own scandals,

but also tie Paxton to the president who is becoming more and more

and popular and losing support among the very voters who boosted him to victory in 2024. Lisa Lair is a national political correspondent for the Times. She says Democrats are feeling confident about their own candidate for Senate, James Tallarico.

No Democrat has won statewide office in Texas for decades, but Tallarico's quickly become a national name, gaining a huge amount of momentum, a lot of fundraising, and his Bible-infused messaging has really resonated in Texas. Democrats feel he'll be a serious contender up against Paxton

and all his baggage. Look, the idea of turning Texas Democratic has been like Charlie Brown in the football for Democrats. They keep trying to get it, and the football the last minute is taken away.

And that could very well happen again. This election cycle, it will be very hard for Democrats to win Texas, which is one of the most stalwartly red states in the country, but they feel that Paxton gives them the best shot that they've had in a really long time.

In the Democratic Republic of Congo, the Ebola outbreak

has now become the third largest on record.

And the Times has learned that the Trump administration is planning to send U.S. citizens who've been exposed to the virus to Kenya, according to several people familiar with those plans. It's a starkly different approach than how past administrations have responded to outbreaks.

In those cases, healthcare workers and other Americans who were exposed to Ebola were brought back to the U.S. to be treated in specialized medical units. One public health expert told the Times he was surprised by the change. Ebola has a high death rate about 50%.

And he said people's chances of getting through in infection would be higher in the specialized facilities. The Times talked with an American doctor who got Ebola back in 2014 when he was treating patients in Guinea. He was then brought home.

And he said he thought it was unlikely that the facility the Trump administration is setting up in Kenya could match the sophistication of what the U.S. already has. He called leaving Americans there, quote, a dramatic abdication of what we owe our own.

A White House spokesman declined to comment. And one last update on the Trump administration. Over his time in office, President Trump has disrupted a lot of funding for medical research. In some cases, it's since been restored.

But the Times has been looking at what even short pauses in grant money have meant for the work. When the funding came back, it wasn't just like turning back on the research light switch, so to say. My colleague Simer Bajaj dug into one research project in particular,

where a biomedical engineer at Cornell University,

Dr.

It is very, very tiny.

The pump is like the size of a AA battery.

Last year, the project seemed close to a big step, starting a clinical trial. The doctor had the right team. A manufacturer was ready to make the device. And an animal study was lined up with sheep just the right size to model a baby

circulatory system. Everything stopped, though, when the Trump administration temporarily

froze more than a billion dollars in funding for the school,

amid a civil rights investigation. And while Cornell later settled with the White House, Simer said, getting things going again has been hard.

He called back his postdoc that he would have been working with,

but that guy had taken a job elsewhere. He wanted to work with his manufacturer to get the device backing up and running, but that didn't manufacturer moved on and he defined someone else. He wanted to restart the animal study, but when he reached back to the farms, the sheep had grown and they weren't the right size anymore to test this device in.

The funding pause was for seven months,

but Dr. Antaki estimates that it set his research back at least double that amount of time. This has been playing out in labs across the country where research has been turned on and off because of the Trump administration's approach to science funding. And really what it reveals is that high-level scientific research is fragile. It depends on timing. It depends on momentum.

And when all this is thrown off, the research and its lifesaving potential is really thrown into question.

In Iran, the government has started restoring internet access for tens of millions of people. They've been largely cut off since the war began three months ago. The Iranian government claimed it was for national security reasons, but many people argued it was imposed to suppress communications and help the regime maintain control of the population.

The blackout hit Iran's already shaky economy, hard, crippling the tech sector, and it made it incredibly difficult for people to just do basic things like reach their friends and loved ones. A 39-year-old woman who works in advertising in Tehran told the times, getting access again has felt like coming out of prison. She said she didn't really know what was happening in the world or with people she hadn't been

able to see in person. She said she just wanted to catch up with friends online, but she also resented that the government's internet shutdown left her craving such a basic thing. She said, quote, "That sense of humiliation is what really bothers people. They feel like hostages in this country. The sad part is that we are starting to get used to it."

One cyber security expert said, "Internet traffic in Iran is going up now, but it's unclear how long that will last."

And finally, in Silicon Valley, AI startups are now everywhere,

promising they can do just about everything. And in that flood, it's become hard for companies to stand out. So they've started making slickly-produced hype videos to try and get attention, filling social media with some bizarre ads. They're trying to catch the eye of talent they may want to recruit or funders who could back

their latest project. In some cases, companies are spending tens of thousands of dollars on production for these videos. And notably, a lot of them are not using AI to make them. They're bringing in actors, full crews, etc. The head of marketing at a company that dropped $80,000 to make a video told the times

they didn't want to use AI because they felt like it would make the company look sloppy. "I feel like people would know. If we had done that, it would just look very cheap." Those are the headlines. I'm Tracy Mumford, I'll be back tomorrow.

Compare and Explore